Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study.

H, Kameda; T, Takeuchi; K, Yamaoka; M, Oribe; M, Kawano; Y, Zhou; AA, Othman; AL, Pangan; S, Kitamura; S, Meerwein; Y, Tanaka

doi:10.1093/rheumatology/keaa084

Public

Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study.

Shared by NobleBlocks on Nov 1, 2020 • 12:00 AM UTC

Authors:

Kameda H

Takeuchi T

Yamaoka K

Abstract

<h4>Objective</h4>To evaluate upadacitinib efficacy and safety dose response in Japanese patients with active RA and an inadequate response to conventional synthetic DMARDs (csDMARDs).<h4>Methods</h4>This was a multicentre, phase IIb/III, dose-ranging study conducted in Japan, in which patients on p...

Subject

Safety

Rheumatoid arthritis

efficacy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!